Efficacy and Safety of Less Frequent/Lower Intensity Dosing of Talquetamab in Patients with Relapsed/Refractory Multiple Myeloma: Results from the Phase 1/2 MonumenTAL-1 Study

Ajai Chari,Albert Oriol, Amrita Krishnan, Maria Del Carmen Martinez Chamorro,Luciano Costa,Maria Victoria Mateos,Monique C Minnema,Michela Campagna,Tara J Masterson,Brandi W Hilder, Jaszianne Tolbert,Thomas Renaud, M. Damiette Smit, Swarna Ramanjulu,Paula Rodríguez Otero

Blood(2023)

Cited 0|Views10
No score
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined